Turning Point Therapeutics, Inc. (TPTX) and trades at $75.49.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -13, Earnings Per Share (EPS) of $-5.79, annual revenue of $30.83M.
The stock has a beta of -0.19, operates in the Healthcare sector.
